Primary aldosteronism: molecular medicine meets public health

EAB Azizan, WM Drake, MJ Brown - Nature Reviews Nephrology, 2023 - nature.com
Primary aldosteronism is the most common single cause of hypertension and is potentially
curable when only one adrenal gland is the culprit. The importance of primary aldosteronism …

Treating primary aldosteronism-induced hypertension: novel approaches and future outlooks

N Mullen, J Curneen, PT Donlon, P Prakash… - Endocrine …, 2024 - academic.oup.com
Primary aldosteronism (PA) is the most common cause of secondary hypertension and is
associated with increased morbidity and mortality when compared with blood pressure …

[HTML][HTML] Somatic mutations of CADM1 in aldosterone-producing adenomas and gap junction-dependent regulation of aldosterone production

X Wu, EAB Azizan, E Goodchild, S Garg, M Hagiyama… - Nature Genetics, 2023 - nature.com
Aldosterone-producing adenomas (APAs) are the commonest curable cause of
hypertension. Most have gain-of-function somatic mutations of ion channels or transporters …

[HTML][HTML] Diagnosis and management of primary hyperaldosteronism in patients with hypertension: a practical approach endorsed by the British and Irish Hypertension …

L Faconti, S Kulkarni, C Delles, V Kapil… - Journal of Human …, 2024 - nature.com
Alongside the lack of homogeneity among international guidelines and consensus
documents on primary hyperaldosteronism, the National UK guidelines on hypertension do …

[HTML][HTML] Time to Benefit of Surgery vs Targeted Medical Therapy for Patients With Primary Aldosteronism: A Meta-analysis

S Samnani, I Cenzer, GA Kline, SJ Lee… - The Journal of …, 2024 - academic.oup.com
Context Primary aldosteronism (PA) is one of the most common causes of secondary
hypertension, but the comparative outcomes of targeted treatment remain unclear …

[HTML][HTML] Mineralocorticoid receptor signalling in primary aldosteronism

J Yang, MJ Young, TJ Cole… - Journal of …, 2023 - joe.bioscientifica.com
Primary aldosteronism, or Conn syndrome, is the most common endocrine cause of
hypertension. It is associated with a higher risk of cardiovascular, metabolic and renal …

[HTML][HTML] A clinical assessment of portable point-of-care testing for quick cortisol assay during adrenal vein sampling

K Aiga, M Kometani, S Karashima, S Konishi… - Scientific Reports, 2023 - nature.com
This study assessed the clinical performance of point-of-care testing (POCT) for quick
cortisol assay (QCA) during adrenal vein sampling (AVS) using a newly invented portable …

[HTML][HTML] Fluorinated aldosterone synthase (CYP11B2)-inhibitors for differential diagnosis between bilateral and unilateral conditions of primary aldosteronism

P Maier, B Heinze, S Gabor, S Reese, S Hahner… - Bioorganic & medicinal …, 2023 - Elsevier
The enzyme aldosterone synthase (CYP11B2) is specifically expressed in aldosterone-
producing tissue of the adrenal cortex and is overexpressed in aldosterone-producing …

[HTML][HTML] Investigation and assessment of adrenal incidentalomas

DJ Cuthbertson, U Alam, AS Davison, J Belfield… - Clinical Medicine, 2023 - Elsevier
With the increasing volume of diagnostic imaging undertaken in an ageing population,
adrenal incidentalomas (AIs) are increasingly commonly seen. These masses are most …

[HTML][HTML] Urine steroid metabolomics as a diagnostic tool in primary aldosteronism

A Prete, K Lang, D Pavlov, Y Rhayem, AJ Sitch… - The Journal of Steroid …, 2024 - Elsevier
Abstract Primary aldosteronism (PA) causes 5–10% of hypertension cases, but only a
minority of patients are currently diagnosed and treated because of a complex, stepwise …